Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation

Pakistan Journal of Pharmaceutical Sciences

Volumn 21, Issue 4, 2008, Pages 455-459

  Rahman, Bytul M ^a   Wahed, Mir Imam Ibne ^a   Khondkar, Proma ^a   Ahmed, Maruf ^a   Islam, Robiul ^a   Barman, Ranjan K ^b   Ul Islam, M Anwar ^a  

^a UNIVERSITY OF RAJSHAHI   (Bangladesh)

^b Quality Compliances Department   (Bangladesh)

Author keywords

Binder; Disintegrant; Lamivudine tablets; Starch 1500; Wet granulation

Indexed keywords

DRUG DERIVATIVE; EXCIPIENT; GELATIN; LAMIVUDINE; POVIDONE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STARCH; STARCH GLYCOLATE SODIUM;

ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DRUG FORMULATION; HARDNESS; METHODOLOGY; PARTICLE SIZE; PHARMACEUTICS; SOLUBILITY; TABLET; TIME;

CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; EXCIPIENTS; GELATIN; HARDNESS; LAMIVUDINE; PARTICLE SIZE; POVIDONE; REVERSE TRANSCRIPTASE INHIBITORS; SOLUBILITY; STARCH; TABLETS; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 58149214646     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Anastasiades A, Thanou S, Loulis D, Stapatoris A and Karapantsios TD (2002). Rheological and physical characterization of pregelatinized maize starches. Journal of Food Engineering, 52(1): 57-66.
2. Banker GS and Anderson NR (1986). Tablets. In: Lachman L, Lieberman HA, Kanig JL, eds. The Theory and Practice of Industrial Pharmacy, Philadelphia, USA: Lea and Febiger Publisher, 293-345.
3. Colorcon Technical Literature (2005).
4. Cunningham CR, Kinsey BR and Scattergood LK (1999). Evaluation of a partially pregelatinized starch in comparison with superdisintegrants in a directcompression hydrochlorothiazide formulation. Poster presented at the American Association of Pharmaceutical Scientists Annual.
5. Cunningham CR, Kinsey BR and Scattergood LK (2001). The effect of STARCH 1500 on the stability of aspirin tablets stored under accelerated conditions. Poster presented at the American Association of Pharmaceutical Scientists Annual Meeting in Denver, CO.
6. Doong SL, Tsai CH and Schinazi RF, Liotta DC and Cheng YC (1991). Inhibition of the replication of hepatitis B virus in vitro by 29,39-dideoxy-39- thiacytidine and related analogues. Proc. Natl. Acad. Sci., 88(19): 8495-8499.
7. Herbert AL, Lean L and Josoph BS (1989). Pharmaceutical dosage forms, tablets, 2nd edition, Marcel Decker, New York, pp. 209-210.
8. Krishna SM, Avinash MC, Hyo YK and Ralph FS (1969). Tableting Properties of a Directly Compressible Starch. J. Phar. Sci., 58: 616-620.
9. Levina M, Taylor J and Rajabi-Siahboomi AR (2001). The influence of Starch 1500 on drug release from HPMC matrices. AAPS National Meeting.
10. Levina M and Cunningham CR (2005). The effect of core design and formulation on the quality of film coated tablets. Pharmaceutical Technology Europe, 17(4): 29-37.
11. Moore JW and Flanner HH (1996). Mathematical Comparison of Dissolution Profile. Pharm. Tech., 20(6): 64-74.
12. Phadke DS and Anderson NR (1990). Effect of crosspovidone on the wet granulation aspects of acetaminophen. Drug Dev. Ind. Pharm., 16: 983-994.
13. Railker AM and Schwartz JB (2001). The effects of formulation factors on the moist granulation technique for controlled release tablets. Drug Dev. Ind. Pharm., 27: 893-898.
14. Wanczinski BJ, Felipe DF, Cardoso ML and Cavalcanti OA (2002). Development of AAS 500 mg tablets: Effect of Starch 1500 on direct compression. Acta Scientiarum, 3: 649-655.